A breakthrough NHS AI blood test may be the most valuable check yet in identifying womb cancer. Several hospitals across England are preparing to use the technology, which uses artificial intelligence to analyze blood samples from patients referred for possible womb cancer before invasive checks are carried out.
According to The Guardian, around 90,000 postmenopausal women in England are referred by general practitioners each year for checks after experiencing heavy bleeding, a symptom that may indicate womb cancer. Currently, these women undergo an invasive check, which can be painful and cause significant distress. However, with the AI blood test, hospitals hope to reduce this number.
The AI system uses machine learning algorithms to analyze blood samples from patients, comparing them to a database of known cases of womb cancer. The results are then used to inform whether further testing is needed, allowing for potentially fewer invasive checks and less trauma to women in need. While the technology is still in its early stages, it has the potential to revolutionize the way doctors diagnose and treat womb cancer, providing faster and more accurate diagnoses than traditional methods.